Integrated Metabolomics and Transcriptomics Analysis of Anacardic Acid Inhibition of Breast Cancer Cell Viability
International Journal of Molecular Sciences · 27.06.2024 · 25 (13) · 7044
DOI: 10.3390/ijms25137044 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2024. Verfasst von Kellianne M Piell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, KY 40292, USA. Hauptthemen laut MEDLINE: Anacardic Acids, Metabolomics, Cell Survival. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Brown Cancer Center, University of Louisville School of Medicine, NIH.
Abstract (Originalsprache)
Anacardic acid (AnAc) inhibits the growth of estrogen receptor α (ERα)-positive MCF-7 breast cancer (BC) cells and MDA-MB-231 triple-negative BC (TNBC) cells, without affecting primary breast epithelial cells. RNA sequencing (seq) and network analysis of AnAc-treated MCF-7 and MDA-MB-231 cells suggested that AnAc inhibited lipid biosynthesis and increased endoplasmic reticulum stress. To investigate the impact of AnAc on cellular metabolism, a comprehensive untargeted metabolomics analysis was performed in five independent replicates of control versus AnAc-treated MCF-7 and MDA-MB-231 cells and additional TNBC cell lines: MDA-MB-468, BT-20, and HCC1806. An analysis of the global metabolome identified key metabolic differences between control and AnAc-treated within each BC cell line and between MCF-7 and the TNBC cell lines as well as metabolic diversity among the four TNBC cell lines, reflecting TNBC heterogeneity. AnAc-regulated metabolites were involved in alanine, aspartate, glutamate, and glutathione metabolism; the pentose phosphate pathway; and the citric acid cycle. Integration of the transcriptome and metabolome data for MCF-7 and MDA-MB-231 identified Signal transduction: mTORC1 downstream signaling in both cell lines and additional cell-specific pathways. Together, these data suggest that AnAc treatment differentially alters multiple pools of cellular building blocks, nutrients, and transcripts resulting in reduced BC cell viability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, KY 40292, USA.
- Department of Biology, University of Louisville, Louisville, KY 40292, USA.
ORCID-Profile: Kellianne M Piell, Carolyn M Klinge
Förderung
- NIH HHS
- Brown Cancer Center, University of Louisville School of Medicine
- NIH
Zitieren
APA
Piell, K. M., Poulton, C. C., Stanley, C. G., Schultz, D. J., & Klinge, C. M. (2024). Integrated Metabolomics and Transcriptomics Analysis of Anacardic Acid Inhibition of Breast Cancer Cell Viability. International Journal of Molecular Sciences, 25(13), 7044. https://doi.org/10.3390/ijms25137044
Vancouver
Piell KM, Poulton CC, Stanley CG, Schultz DJ, Klinge CM. Integrated Metabolomics and Transcriptomics Analysis of Anacardic Acid Inhibition of Breast Cancer Cell Viability. International Journal of Molecular Sciences. 2024;25(13):7044. doi:10.3390/ijms25137044
BibTeX
@article{Piell2024,
author = {Piell, Kellianne M and Poulton, Claire C and Stanley, Christian G and Schultz, David J and Klinge, Carolyn M},
title = {Integrated Metabolomics and Transcriptomics Analysis of Anacardic Acid Inhibition of Breast Cancer Cell Viability},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7044},
doi = {10.3390/ijms25137044}
}
EUVIMED